-
Comparative Clinical Effectiveness of Analgesics for the Treatment of Moderate-to-Severe Acute Pain: A Systematic Review and Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Real-World Adherence, Healthcare Resource Utilization, And Costs Among Patients With Schizophrenia Utilizing Once-Monthly, Once-Every-Three-Months, And Once-Every-Six-Months Paliperidone Palmitate in the United States
Mar 10, 2025, 14:00 PM -
Evaluating the Cost-Effectiveness of Polygenic Risk Score-Guided Breast Cancer Screening Using a Discrete Event Simulation Model
Mar 10, 2025, 14:00 PM -
Trends In Oral JAK Inhibitor And Other Drug Use For Myelofibrosis: A Retrospective Real-World Study
Mar 10, 2025, 14:00 PM -
Approaches to Model Patient And Carer Utilities and Disutilities of Adverse Events in Economic Models for Rare Disease Treatments in NICE Appraisals
Mar 10, 2025, 14:00 PM -
Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases
Mar 10, 2025, 14:00 PM -
Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database
Mar 10, 2025, 14:00 PM -
Evaluating the Influence of User-Complexity on Individual Preferences for Upper Limb Prosthetic Selection: Measurement Tool Development for a Discrete Choice Experiment
Mar 10, 2025, 14:00 PM -
Blood Phenylalanine (Phe) Levels in Individuals With Phenylketonuria (PKU): A United States Electronic Health Records (US EHR) and Medical Notes Study
Mar 10, 2025, 14:00 PM -
Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development
Mar 10, 2025, 14:00 PM -
Estimated Total Cost of Care (TCC) of First-Line (1L) Fixed-Duration BCL2i versus Treat-To-Progression BTKi Regimens in Patients with Chronic Lymphocytic Leukemia (CLL) in the United States (US): A Population-Based Model
Mar 10, 2025, 14:00 PM -
More than "financial toxicity": the Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives
Mar 10, 2025, 14:00 PM -
Using the Potential Outcomes Model to Inform the Design and Interpretation of Causal Studies of the Effectiveness and Safety of Healthcare Interventions: An Interdisciplinary Perspective
Mar 10, 2025, 14:00 PM -
Assessment of Real-World Adverse Events Associated with Ozanimod in Relapsing Remitting Multiple Sclerosis (RRMS)
Mar 10, 2025, 14:00 PM -
Clinical Value of Testing for c-Met Protein Overexpression in Patients With Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review
Mar 10, 2025, 14:00 PM -
Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring:A Population-Based Study
Mar 10, 2025, 14:00 PM -
Predictors of Low Disease Activity/ Remission Amongst Rheumatoid Arthritis Patients Experiencing Inadequate Response to Biologic/ Targeted Synthetic Disease-Modifying Antirheumatic Drugs
Mar 10, 2025, 14:00 PM -
Sociodemographic Variations in Perceived Social Support Among Adults with Depression in the United States: Results From the National Health and Wellness Survey
Mar 10, 2025, 14:00 PM -
Perceptions of Private Health Insurance Among Households in a Small Island Developing State (SIDS): The Case of Grenada
Mar 10, 2025, 14:00 PM
